Company news
Sk Biopharmaceuticals Co., Ltd. (KRX:326030) news
Sk Biopharmaceuticals Co., Ltd. news releases on 6ix. Latest, Apr 6, 2026: SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026…
Press releases & updates
SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting
April 6, 2026
SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation
November 25, 2025
SK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting
November 21, 2025
New SK Life Science, Inc. Survey Reveals Communication Gaps Between Patients and Providers That Can Impact Epilepsy Care Outcomes
October 28, 2025
SK Life Science, Inc. to Host "Illuminating the Path to Added Seizure Reduction" Symposium at the 2025 American Epilepsy Society Annual Meeting
October 24, 2025
SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform
October 19, 2025